[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555350":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":39,"responsibleParty":56,"collaborators":18,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":60,"sex":66,"minAge":67,"maxAge":18,"enrollmentInfo":68,"targetDuration":18,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":80,"overallStatus":83,"whyStopped":18,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Universidad Miguel Hernandez de Elche","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention group","EXPERIMENTAL","Intervention group: health education, use of mobile phones, personalized dosage system.",[13],"Behavioral: (Health education program) To increase therapeutic adherence in patients with secondary prevention for cardiovascular disease",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","NO_INTERVENTION","Routine follow-up.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","(Health education program) To increase therapeutic adherence in patients with secondary prevention for cardiovascular disease","The intervention involves a comprehensive health education program based on the Chronic Care Model to increase therapeutic adherence in patients with secondary prevention for cardiovascular disease. The program includes the following components:\n\nHealth Education Sessions: Education on the importance of adherence, understanding the disease, side effects of medications, and their management. It addresses personal beliefs and concerns.\n\nMobile Phone Reminders: Use of alarms and the ti.care® app to remind patients to take their medications.\n\nMedication Verification: Ensuring that the medications and dosages taken match the prescriptions.\n\nPersonalized Dosing Systems (PDS): Helping manage medication intake.\n\nAdditional Health Advice: Control of other cardiovascular risk factors and benefits of the Mediterranean diet.",[9],[26],{"name":27,"affiliation":28,"role":29},"Francisco Manuel Lidón Muñoz","Universidad Miguel Hernández de Elche","PRINCIPAL_INVESTIGATOR",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Francisco Manuel Lidón Muñoz, Doctor","CONTACT","+34 965918550","francisco.lidon@goumh.umh.es",{"name":37,"role":33,"phone":18,"phoneExt":18,"email":38},"Domingo Luis Orozco Beltrán, Professor","dorozco@umh.es",[40],{"facility":41,"status":18,"city":42,"state":18,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Babel Health Centre","Alicante","03007","Spain","ES",{"type":47,"coordinates":48},"Point",[49,50],-0.48149,38.34517,{"lat":50,"lon":49},[53,54],{"name":27,"role":33,"phone":18,"phoneExt":18,"email":35},{"name":55,"role":33,"phone":18,"phoneExt":18,"email":18},"Domingo Luis Orozco Beltrán",{"type":29,"investigatorFullName":27,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Bachelor's in Medicine. PhD student.","100555350","improving-therapeutic-adherence-in-cardiovascular-secondary-prevention-100555350",false,"NCT06510946","Improving Therapeutic Adherence in Cardiovascular Secondary Prevention.","Efficacy of an Intervention to Increase Therapeutic Adherence in Patients With Secondary Prevention for Cardiovascular Disease.","AT-PSC","Inclusion Criteria:\n\n* Patients of both sexes, aged over 18 years old, who, after reading the patient information sheet, provide written informed consent.\n* Patients in secondary prevention receiving daily single-dose angiotensin converting enzyme inhibitors\u002FAngiotensin II receptor blockers, acetylsalicylic acid, and statins for 6 months or more.\n* Diagnosis of any of the following cardiovascular diseases: cerebrovascular disease, ischemic heart disease, or peripheral vascular disease.\n* Patients under follow-up at our primary care center.\n* Patients identified with therapeutic adherence deficiency, defined as Haynes-Sackett test supplemented with Medication Possession Ratio (MPR) \\\u003C 80% for any of the 3 drugs in the previous 6 months.\n\nExclusion Criteria:\n\n* Patients who refuse to participate.\n* Incomplete completion of informed consent.\n* Language barrier.\n* Patients diagnosed with psychiatric, psychological, neurological, and\u002For social problems that hinder intervention or follow-up.\n* Life expectancy less than one year.\n* Patients whose treatment is managed by a caregiver (professional or family member).\n* Patients with Barthel Index \\\u003C60.\n* Institutionalized patients.\n* Patients currently participating in similar research studies.","ALL","18 Years",{"count":69,"type":70},90,"ESTIMATED","INTERVENTIONAL",[73],"NA","The goal of this open label randomized controlled trial is to evaluate the efficacy of an intervention through health education based on the Chronic Care Model's implementation to increase therapeutic adherence in patients with secondary prevention for cardiovascular disease. The main questions it aims to answer are:\n\n* Null hypothesis (H0): In patients in cardiovascular secondary prevention, an intervention based on the application of the Chronic Care Model does not improve therapeutic adherence to the 3 preventive drugs: Angiotensin converting enzyme inhibitors\u002FAngiotensin II receptor blockers, acetylsalicylic acid, and statins.\n* Alternative hypothesis (H1): In patients in cardiovascular secondary prevention, an intervention based on the application of the Chronic Care Model improves therapeutic adherence to the 3 preventive drugs: Angiotensin converting enzyme inhibitors\u002FAngiotensin II receptor blockers, acetylsalicylic acid, and statins.\n\nResearchers will compare intervention group (health education, use of mobile phones, personalized dosage system) to the control group (routine follow-up).",[76,77,78,79],"Cardiovascular Diseases","Chronic Disease","Secondary Prevention","Coronary Disease",[81,82],"Treatment Adherence and Compliance","Primary Health Care","NOT_YET_RECRUITING","2024-07-18",{"date":86,"type":87},"2024-07-19","ACTUAL",{"date":89,"type":70},"2025-01",{"date":91,"type":70},"2026-01",{"name":5,"class":6},1]